{"protocolSection":{"identificationModule":{"nctId":"NCT00157248","orgStudyIdInfo":{"id":"1160.42"},"organization":{"fullName":"Boehringer Ingelheim","class":"INDUSTRY"},"briefTitle":"Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048","officialTitle":"Long-term, Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial (Trial 1160.20 - NCT01227629). (PETRO Extension Trial: PETRO-Ex)"},"statusModule":{"statusVerifiedDate":"2014-02","overallStatus":"TERMINATED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2003-12"},"primaryCompletionDateStruct":{"date":"2009-01","type":"ACTUAL"},"studyFirstSubmitDate":"2005-09-08","studyFirstSubmitQcDate":"2005-09-08","studyFirstPostDateStruct":{"date":"2005-09-12","type":"ESTIMATED"},"resultsFirstSubmitDate":"2010-11-18","resultsFirstSubmitQcDate":"2011-01-11","resultsFirstPostDateStruct":{"date":"2011-02-03","type":"ESTIMATED"},"lastUpdateSubmitDate":"2014-05-08","lastUpdatePostDateStruct":{"date":"2014-05-19","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Boehringer Ingelheim, Study Chair","oldOrganization":"Boehringer Ingelheim"},"leadSponsor":{"name":"Boehringer Ingelheim","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion, with or without concomitant chronic treatment with acetylsalicylic acid (ASA)."},"conditionsModule":{"conditions":["Atrial Fibrillation","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"NON_RANDOMIZED","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":361,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"dabigatran etexilate, 150 mg once daily","type":"EXPERIMENTAL","description":"dosage used at study start","interventionNames":["Drug: dabigatran etexilate"]},{"label":"dabigatran etexilate, 150 mg twice daily","type":"EXPERIMENTAL","description":"dosage used at study start","interventionNames":["Drug: dabigatran etexilate"]},{"label":"dabigatran etexilate, 300 mg once daily","type":"EXPERIMENTAL","description":"dosage used at study start","interventionNames":["Drug: dabigatran etexilate"]},{"label":"dabigatran etexilate, 300 mg twice daily","type":"EXPERIMENTAL","description":"dosage used at study start","interventionNames":["Drug: dabigatran etexilate"]}],"interventions":[{"type":"DRUG","name":"dabigatran etexilate","description":"dosage used at study start","armGroupLabels":["dabigatran etexilate, 150 mg once daily"]},{"type":"DRUG","name":"dabigatran etexilate","description":"dosage used at study start","armGroupLabels":["dabigatran etexilate, 150 mg twice daily"]},{"type":"DRUG","name":"dabigatran etexilate","description":"dosage used at study start","armGroupLabels":["dabigatran etexilate, 300 mg once daily"]},{"type":"DRUG","name":"dabigatran etexilate","description":"dosage used at study start","armGroupLabels":["dabigatran etexilate, 300 mg twice daily"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Yearly Event Rate for Composite Endpoint of Stroke, Transient Ischaemic Attacks, System Thromboembolism, Myocardial Infarction, Other Major Adverse Cardiac Events and Mortality.","description":"Time to first occurrence of stroke, transient ischaemic attacks, system thromboembolism, myocardial infarction, other major adverse cardiac events and mortality. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Major Bleeding","description":"Time to first occurrence of fatal or life-threatening, retroperitoneal, intracranial, intraocular, or intraspinal bleeding, which required surgical treatment, led to a transfusion of a minimum of 2 units of packed cells or whole blood, or led to a fall in hemoglobin of 20g/L or less.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Major + Minor/Relevant Bleeding","description":"Time to first occurrence of either major or minor/relevant bleeding. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Any Bleeding","description":"Time to first occurrence of any bleeding event. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Minor Bleeding","description":"Time to first occurrence of minor bleeding. A minor bleeding event is any bleed that does not qualify as a major bleed. All minor bleeding events not fulfilling one of the criteria for clinically relevant were classified as nuisance bleeds.\n\nClinically-relevant was defined as spontaneous skin hematoma ≥25 cm², spontaneous nose bleed \\>5 min, macroscopic hematuria spontaneous or lasting longer than 24 hours if associated with an intervention, spontaneous rectal bleeding, gingival bleeding \\>5 min, leading to hospitalization, leading to a transfusion of \\<2 units of packed cells or whole blood and any other bleeding event considered clinically relevant by the investigator.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"}],"secondaryOutcomes":[{"measure":"Yearly Event Rate for Stroke","description":"Time to first occurrence of any fatal or non-fatal stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate of Ischaemic Stroke","description":"Time to first occurrence of any ischaemic stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate of Haemorrhagic Stroke","description":"Time to first occurrence of any haemorrhagic stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Transient Ischaemic Attacks","description":"Time to first occurrence of any transient ischaemic attacks. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Systemic Thromboembolism","description":"Time to first occurrence of any non-central nervous system systemic thromboembolism.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate of Myocardial Infarction","description":"Time to first occurrence of any myocardial infarction. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate of Other Major Adverse Cardiac Events","description":"Time to first occurrence of any other major adverse cardiac events. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate of Death","description":"Time to death of any cause. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Yearly Event Rate for Composite Secondary Endpoint of Ischaemic Stroke, Transient Ischaemic Attacks, Non-central Nervous System Systemic Thromboembolism, Myocardial Infarction, Other Major Adverse Cardiac Events and All-cause Mortality","description":"Time to first occurrence of ischaemic stroke, transient ischaemic attacks, non-central nervous system systemic thromboembolism, myocardial infarction, other major adverse cardiac events and all-cause mortality.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","timeFrame":"5 years"},{"measure":"Severe Adverse Event","description":"Frequency of patients with severe adverse events.","timeFrame":"5 years"},{"measure":"Laboratory Analyses","description":"Frequency of patients with possible clinically significant abnormalities, i.e. with values out of normal range.\n\nNormal ranges are defined as:\n\n* Alanine aminotransferase (ALT): 5-45 \\[U/L\\]\n* Aspartate aminotransferase (AST): 10-40 \\[U/L\\]\n* Bilirubin, total: 0.2-1.0 \\[mg/dL\\]","timeFrame":"5 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria Diagnosis and main criteria for inclusion: Paroxysmal, persistent, or permanent (chronic) non-rheumatic atrial fibrillation with a history of coronary artery disease (CAD)\n\nInclusion Criteria:\n\n* previous treatment with BIBR 1048 in PETRO (trial 1160.20- NCT01227629) and no premature discontinuation of therapy\n* paroxysmal, persistent, or permanent (chronic) non-rheumatic atrial fibrillation, documented by electrocardiogram (ECG) at least twice prior to enrollment in PETRO\n* concomitant coronary artery disease -an additional risk factor for stroke (one or more of the following conditions/events): hypertension, diabetes mellitus (DM), congestive heart failure (CHF) or Left ventricular dysfunction (LVD), previous ischemic stroke or transient ischemic attack) TIA, or age greater than 75 years. -age \\>= 18 years\n* written, informed consent\n\nExclusion criteria\n\nExclusion Criteria:\n\n* Valvular heart disease conferring significantly increased risk of thromboembolic events (e.g. clinically significant mitral stenosis or prosthetic valves). planned cardioversion while patients are in the study.\n* contraindication to anticoagulant therapy (previous intracranial hemorrhage, gastro-intestinal (GI) hemorrhage within previous 3 months, previous severe hemorrhage with warfarin at therapeutic international normalized ratio (INR), regular use of non-steroidal anti-inflammatory drugs, hemorrhagic diathesis) major bleeding within the last 6 months (other than GI hemorrhage).\n* severe renal impairment (estimated glomerular filtration rate \\[GFR\\] \\<= 30 mL/min). uncontrolled hypertension (systolic blood pressure \\[SBP\\] \\> 180 mm Hg and/or diastolic blood pressure \\[DBP\\] \\> 100 mmHg).\n* Women who are pregnant or of childbearing potential who refuse to use a medically acceptable form of contraception throughout the study (note: a negative pregnancy test must be obtained for any woman of childbearing potential prior to entry into the study).\n* Patients who have received an investigational drug other than BIBR 1048 within the last 30 days.\n* Patients considered unreliable by the investigator concerning the requirements for follow-up during the study and/or compliance with study drug administration. Another indication for anticoagulant treatment (eg, deep vein thrombosis or pulmonary embolus). Clinically significant anemia (note: patients with mild-moderate anemia should only be enrolled after the possibility of a GI bleeding source has been evaluated, the etiology of the anemia identified, and appropriate action taken). Patients suffering from thrombocytopenia (platelets \\< 100,000/uL). Any other condition which, in the discretion of the investigator, would not allow safe participation in the study.\n* Continuing or planned concomitant treatment with antiplatelet agents other than acetylsalicylic acid (ASA).\n* Recent malignancy or radiation therapy (\\<= 6 months).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Boehringer Ingelheim","affiliation":"Boehringer Ingelheim","role":"STUDY_CHAIR"}],"locations":[{"facility":"1160.42.10003 Boehringer Ingelheim Investigational Site","city":"La Mesa","state":"California","country":"United States","geoPoint":{"lat":32.76783,"lon":-117.02308}},{"facility":"1160.42.10006 Boehringer Ingelheim Investigational Site","city":"Pensacola","state":"Florida","country":"United States","geoPoint":{"lat":30.42131,"lon":-87.21691}},{"facility":"1160.42.10004 Boehringer Ingelheim Investigational Site","city":"Port Charlotte","state":"Florida","country":"United States","geoPoint":{"lat":26.97617,"lon":-82.09064}},{"facility":"1160.42.10002 Boehringer Ingelheim Investigational Site","city":"St. Petersburg","state":"Florida","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"1160.42.10015 Boehringer Ingelheim Investigational Site","city":"Baltimore","state":"Maryland","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"1160.42.10008 Boehringer Ingelheim Investigational Site","city":"Westminster","state":"Maryland","country":"United States","geoPoint":{"lat":39.57538,"lon":-76.99581}},{"facility":"1160.42.10012 Boehringer Ingelheim Investigational Site","city":"Pittsfield","state":"Massachusetts","country":"United States","geoPoint":{"lat":42.45008,"lon":-73.24538}},{"facility":"1160.42.10007 Boehringer Ingelheim Investigational Site","city":"Troy","state":"Michigan","country":"United States","geoPoint":{"lat":42.60559,"lon":-83.14993}},{"facility":"1160.42.10014 Boehringer Ingelheim Investigational Site","city":"Hawthorne","state":"New York","country":"United States","geoPoint":{"lat":41.10732,"lon":-73.79597}},{"facility":"1160.42.10013 Boehringer Ingelheim Investigational Site","city":"New Hyde Park","state":"New York","country":"United States","geoPoint":{"lat":40.7351,"lon":-73.68791}},{"facility":"1160.42.10009 Boehringer Ingelheim Investigational Site","city":"North Durham","state":"North Carolina","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}},{"facility":"1160.42.10001 Boehringer Ingelheim Investigational Site","city":"Philadelphia","state":"Pennsylvania","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"1160.42.45010 Boehringer Ingelheim Investigational Site","city":"Aalborg","country":"Denmark","geoPoint":{"lat":57.048,"lon":9.9187}},{"facility":"1160.42.45005 Boehringer Ingelheim Investigational Site","city":"Aarhus C","country":"Denmark","geoPoint":{"lat":56.15674,"lon":10.21076}},{"facility":"1160.42.45007 Boehringer Ingelheim Investigational Site","city":"Brædstrup","country":"Denmark","geoPoint":{"lat":55.97153,"lon":9.61129}},{"facility":"1160.42.45011 Boehringer Ingelheim Investigational Site","city":"Esbjerg","country":"Denmark","geoPoint":{"lat":55.47028,"lon":8.45187}},{"facility":"1160.42.45012 Boehringer Ingelheim Investigational Site","city":"Frederikssund","country":"Denmark","geoPoint":{"lat":55.83956,"lon":12.06896}},{"facility":"1160.42.45003 Boehringer Ingelheim Investigational Site","city":"Helsingør","country":"Denmark","geoPoint":{"lat":56.03606,"lon":12.6136}},{"facility":"1160.42.45004 Boehringer Ingelheim Investigational Site","city":"Herlev","country":"Denmark","geoPoint":{"lat":55.72366,"lon":12.43998}},{"facility":"1160.42.45009 Boehringer Ingelheim Investigational Site","city":"Holbæk","country":"Denmark","geoPoint":{"lat":55.71354,"lon":11.7169}},{"facility":"1160.42.45002 Boehringer Ingelheim Investigational Site","city":"Hvidovre","country":"Denmark","geoPoint":{"lat":55.65719,"lon":12.47364}},{"facility":"1160.42.45014 Boehringer Ingelheim Investigational Site","city":"Køge","country":"Denmark","geoPoint":{"lat":55.45802,"lon":12.18214}},{"facility":"1160.42.45001 Boehringer Ingelheim Investigational Site","city":"Odense","country":"Denmark","geoPoint":{"lat":55.39594,"lon":10.38831}},{"facility":"1160.42.45013 Roskilde Sygehus","city":"Roskilde","country":"Denmark","geoPoint":{"lat":55.64152,"lon":12.08035}},{"facility":"1160.42.45006 Boehringer Ingelheim Investigational Site","city":"Svendborg","country":"Denmark","geoPoint":{"lat":55.05982,"lon":10.60677}},{"facility":"1160.42.31003 Ziekenhuis Amstelveen","city":"Amstelveen","country":"Netherlands","geoPoint":{"lat":52.30083,"lon":4.86389}},{"facility":"1160.42.31001 Academisch Medisch Centrum","city":"Amsterdam","country":"Netherlands","geoPoint":{"lat":52.37403,"lon":4.88969}},{"facility":"1160.42.31013 Onze Lieve Vrouwe Gasthuis","city":"Amsterdam","country":"Netherlands","geoPoint":{"lat":52.37403,"lon":4.88969}},{"facility":"1160.42.31008 Gelre Ziekenhuis, locatie Juliana","city":"Apeldoorn","country":"Netherlands","geoPoint":{"lat":52.21,"lon":5.96944}},{"facility":"1160.42.31006 Wilhelmina Ziekenhuis","city":"Assen","country":"Netherlands","geoPoint":{"lat":52.99667,"lon":6.5625}},{"facility":"1160.42.31007 Gemini Ziekenhuis","city":"Den Helder","country":"Netherlands","geoPoint":{"lat":52.95988,"lon":4.75933}},{"facility":"1160.42.31002 Ziekenhuis Gelderse Vallei","city":"Ede","country":"Netherlands","geoPoint":{"lat":52.03333,"lon":5.65833}},{"facility":"1160.42.31014 Ziekenhuisgroep Twente","city":"Hengelo","country":"Netherlands","geoPoint":{"lat":52.26583,"lon":6.79306}},{"facility":"1160.42.31012 Vasculair onderzoekscentrum (VOC)","city":"Hoorn","country":"Netherlands","geoPoint":{"lat":52.6425,"lon":5.05978}},{"facility":"1160.42.31009 Havenziekenhuis","city":"Rotterdam","country":"Netherlands","geoPoint":{"lat":51.9225,"lon":4.47917}},{"facility":"1160.42.31004 Maasland Ziekenhuis","city":"Sittard","country":"Netherlands","geoPoint":{"lat":50.99833,"lon":5.86944}},{"facility":"1160.42.31005 Tweesteden Ziekenhuis","city":"Tilburg","country":"Netherlands","geoPoint":{"lat":51.55551,"lon":5.0913}},{"facility":"1160.42.31011 Maxima Medisch Centrum","city":"Veldhoven","country":"Netherlands","geoPoint":{"lat":51.41833,"lon":5.40278}},{"facility":"1160.42.46013 Boehringer Ingelheim Investigational Site","city":"Eskilstuna","country":"Sweden","geoPoint":{"lat":59.36661,"lon":16.5077}},{"facility":"1160.42.46007 Boehringer Ingelheim Investigational Site","city":"Falun","country":"Sweden","geoPoint":{"lat":60.60357,"lon":15.62597}},{"facility":"1160.42.46005 Boehringer Ingelheim Investigational Site","city":"Jönköping","country":"Sweden","geoPoint":{"lat":57.78145,"lon":14.15618}},{"facility":"1160.42.46010 Boehringer Ingelheim Investigational Site","city":"Kalmar","country":"Sweden","geoPoint":{"lat":56.66157,"lon":16.36163}},{"facility":"1160.42.46009 Boehringer Ingelheim Investigational Site","city":"Malmö","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"1160.42.46008 Boehringer Ingelheim Investigational Site","city":"Norrköping","country":"Sweden","geoPoint":{"lat":58.59419,"lon":16.1826}},{"facility":"1160.42.46002 Boehringer Ingelheim Investigational Site","city":"Stockholm","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}},{"facility":"1160.42.46011 Boehringer Ingelheim Investigational Site","city":"Stockholm","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}},{"facility":"1160.42.46006 Boehringer Ingelheim Investigational Site","city":"Umeaa","country":"Sweden"},{"facility":"1160.42.46001 Boehringer Ingelheim Investigational Site","city":"Uppsala","country":"Sweden","geoPoint":{"lat":59.85882,"lon":17.63889}},{"facility":"1160.42.46003 Boehringer Ingelheim Investigational Site","city":"Västerås","country":"Sweden","geoPoint":{"lat":59.61617,"lon":16.55276}},{"facility":"1160.42.46004 Boehringer Ingelheim Investigational Site","city":"Örebro","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"In this non-randomized follow-up study, events are displayed cumulatively that occurred in the initial study (1160.20) or in the present study.","recruitmentDetails":"This was a non-randomized open-label extension study of study 1160.20. Patients initially continued Dabigatran treatment of 1160.20; per protocol amendment, most patients moved to 150 mg bid. All events were assigned to the Dabigatran regimen that a patient received prior to the event and patients may be counted in multiple regimens","groups":[{"id":"FG000","title":"Dabigatran Etexilate, 150 mg QD (Once Daily)","description":"Dosage used at study start"},{"id":"FG001","title":"Dabigatran Etexilate, 150 mg BID (Twice Daily)","description":"Dosage used at study start"},{"id":"FG002","title":"Dabigatran Etexilate, 300 mg QD (Once Daily)","description":"Dosage used at study start"},{"id":"FG003","title":"Dabigatran Etexilate, 300 mg BID (Twice Daily)","description":"Dosage used at study start"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","comment":"Started: Participant completed previous trial on Dabigatran and took study drug of present trial.","numSubjects":"98"},{"groupId":"FG001","numSubjects":"89"},{"groupId":"FG002","numSubjects":"50"},{"groupId":"FG003","numSubjects":"124"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","comment":"Completed: Participant without premature discontinuation of study medication.","numSubjects":"50"},{"groupId":"FG001","numSubjects":"52"},{"groupId":"FG002","numSubjects":"29"},{"groupId":"FG003","numSubjects":"77"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"37"},{"groupId":"FG002","numSubjects":"21"},{"groupId":"FG003","numSubjects":"47"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"36"},{"groupId":"FG001","numSubjects":"25"},{"groupId":"FG002","numSubjects":"13"},{"groupId":"FG003","numSubjects":"33"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"2"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"}]},{"type":"site closures, subject moving","reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"9"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"All patients in follow-up study.","groups":[{"id":"BG000","title":"Dabigatran Etexilate, 150 mg QD (Once Daily)","description":"Dosage used at study start"},{"id":"BG001","title":"Dabigatran Etexilate, 150 mg BID (Twice Daily)","description":"Dosage used at study start"},{"id":"BG002","title":"Dabigatran Etexilate, 300 mg QD (Once Daily)","description":"Dosage used at study start"},{"id":"BG003","title":"Dabigatran Etexilate, 300 mg BID (Twice Daily)","description":"Dosage used at study start"},{"id":"BG004","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"98"},{"groupId":"BG001","value":"89"},{"groupId":"BG002","value":"50"},{"groupId":"BG003","value":"124"},{"groupId":"BG004","value":"361"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"70.4","spread":"8.6"},{"groupId":"BG001","value":"69.3","spread":"8.2"},{"groupId":"BG002","value":"71.0","spread":"6.8"},{"groupId":"BG003","value":"68.8","spread":"8.5"},{"groupId":"BG004","value":"69.7","spread":"8.2"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"59"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"40"},{"groupId":"BG003","value":"112"},{"groupId":"BG004","value":"302"}]}]}]},{"title":"Atrial fibrillation","description":"Atrial fibrillation measured at baseline","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"Persistent","categories":[{"measurements":[{"groupId":"BG000","value":"40","spread":"139"},{"groupId":"BG001","value":"38","spread":"40"},{"groupId":"BG002","value":"15","spread":"38"},{"groupId":"BG003","value":"46","spread":"15"},{"groupId":"BG004","value":"139"}]}]},{"title":"Permanent","categories":[{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"25"},{"groupId":"BG003","value":"47"},{"groupId":"BG004","value":"140"}]}]},{"title":"Paroxysmal","categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"31"},{"groupId":"BG004","value":"82"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Yearly Event Rate for Composite Endpoint of Stroke, Transient Ischaemic Attacks, System Thromboembolism, Myocardial Infarction, Other Major Adverse Cardiac Events and Mortality.","description":"Time to first occurrence of stroke, transient ischaemic attacks, system thromboembolism, myocardial infarction, other major adverse cardiac events and mortality. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"17.0"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"5.7"},{"groupId":"OG004","value":"4.5"},{"groupId":"OG005","value":"2.4"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate for Stroke","description":"Time to first occurrence of any fatal or non-fatal stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"4.3"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"1.1"},{"groupId":"OG004","value":"1.7"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate of Ischaemic Stroke","description":"Time to first occurrence of any ischaemic stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"4.3"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"0.5"},{"groupId":"OG004","value":"1.7"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate of Haemorrhagic Stroke","description":"Time to first occurrence of any haemorrhagic stroke. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"0.6"},{"groupId":"OG004","value":"0.0"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate for Transient Ischaemic Attacks","description":"Time to first occurrence of any transient ischaemic attacks. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"0.2"},{"groupId":"OG004","value":"0.4"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate for Systemic Thromboembolism","description":"Time to first occurrence of any non-central nervous system systemic thromboembolism.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"8.5"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"0.2"},{"groupId":"OG004","value":"0.4"},{"groupId":"OG005","value":"1.2"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate of Myocardial Infarction","description":"Time to first occurrence of any myocardial infarction. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"1.1"},{"groupId":"OG004","value":"0.4"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate of Other Major Adverse Cardiac Events","description":"Time to first occurrence of any other major adverse cardiac events. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"8.5"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"1.1"},{"groupId":"OG004","value":"0.8"},{"groupId":"OG005","value":"1.2"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate of Death","description":"Time to death of any cause. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"2.7"},{"groupId":"OG004","value":"2.1"},{"groupId":"OG005","value":"0.0"}]}]}]},{"type":"PRIMARY","title":"Yearly Event Rate for Major Bleeding","description":"Time to first occurrence of fatal or life-threatening, retroperitoneal, intracranial, intraocular, or intraspinal bleeding, which required surgical treatment, led to a transfusion of a minimum of 2 units of packed cells or whole blood, or led to a fall in hemoglobin of 20g/L or less.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"},{"groupId":"OG002","value":"6.6"},{"groupId":"OG003","value":"3.1"},{"groupId":"OG004","value":"0.8"},{"groupId":"OG005","value":"7.3"}]}]}]},{"type":"PRIMARY","title":"Yearly Event Rate for Major + Minor/Relevant Bleeding","description":"Time to first occurrence of either major or minor/relevant bleeding. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"8.5"},{"groupId":"OG002","value":"11.6"},{"groupId":"OG003","value":"7.6"},{"groupId":"OG004","value":"6.6"},{"groupId":"OG005","value":"26.8"}]}]}]},{"type":"PRIMARY","title":"Yearly Event Rate for Any Bleeding","description":"Time to first occurrence of any bleeding event. Yearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"25.5"},{"groupId":"OG002","value":"21.5"},{"groupId":"OG003","value":"14.7"},{"groupId":"OG004","value":"14.9"},{"groupId":"OG005","value":"58.5"}]}]}]},{"type":"SECONDARY","title":"Yearly Event Rate for Composite Secondary Endpoint of Ischaemic Stroke, Transient Ischaemic Attacks, Non-central Nervous System Systemic Thromboembolism, Myocardial Infarction, Other Major Adverse Cardiac Events and All-cause Mortality","description":"Time to first occurrence of ischaemic stroke, transient ischaemic attacks, non-central nervous system systemic thromboembolism, myocardial infarction, other major adverse cardiac events and all-cause mortality.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"17.0"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"5.5"},{"groupId":"OG004","value":"4.5"},{"groupId":"OG005","value":"2.4"}]}]}]},{"type":"SECONDARY","title":"Severe Adverse Event","description":"Frequency of patients with severe adverse events.","populationDescription":"All treated patients.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"96"},{"groupId":"OG004","value":"28"},{"groupId":"OG005","value":"16"}]}]}]},{"type":"PRIMARY","title":"Yearly Event Rate for Minor Bleeding","description":"Time to first occurrence of minor bleeding. A minor bleeding event is any bleed that does not qualify as a major bleed. All minor bleeding events not fulfilling one of the criteria for clinically relevant were classified as nuisance bleeds.\n\nClinically-relevant was defined as spontaneous skin hematoma ≥25 cm², spontaneous nose bleed \\>5 min, macroscopic hematuria spontaneous or lasting longer than 24 hours if associated with an intervention, spontaneous rectal bleeding, gingival bleeding \\>5 min, leading to hospitalization, leading to a transfusion of \\<2 units of packed cells or whole blood and any other bleeding event considered clinically relevant by the investigator.\n\nYearly event rate (%) = number of subjects with event / subject-years \\* 100. Subject years = sum (date of end of treatment - date of start of treatment) of all entered subjects / 365.25","populationDescription":"All treated patients. In this non-randomized follow-up study, most patients changed treatment regimens per amendment during conduct and treatment exposure was not comparable between regimens. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens. No statistical analysis was done.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"yearly event rate (percentage)","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"title":"Clinically relevant","categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"8.5"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"4.5"},{"groupId":"OG004","value":"5.8"},{"groupId":"OG005","value":"19.5"}]}]},{"title":"Nuisance only","categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"17.0"},{"groupId":"OG002","value":"9.9"},{"groupId":"OG003","value":"7.1"},{"groupId":"OG004","value":"8.3"},{"groupId":"OG005","value":"31.7"}]}]}]},{"type":"SECONDARY","title":"Laboratory Analyses","description":"Frequency of patients with possible clinically significant abnormalities, i.e. with values out of normal range.\n\nNormal ranges are defined as:\n\n* Alanine aminotransferase (ALT): 5-45 \\[U/L\\]\n* Aspartate aminotransferase (AST): 10-40 \\[U/L\\]\n* Bilirubin, total: 0.2-1.0 \\[mg/dL\\]","populationDescription":"All treated patients.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"5 years","groups":[{"id":"OG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily"},{"id":"OG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily"},{"id":"OG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily"},{"id":"OG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily"},{"id":"OG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily"},{"id":"OG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"102"},{"groupId":"OG003","value":"356"},{"groupId":"OG004","value":"90"},{"groupId":"OG005","value":"161"}]}],"classes":[{"title":"AST > 3*ULN","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}]}]},{"title":"ALT > 3*ULN","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"2"}]}]},{"title":"Bilirubin > 2*ULN","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"5 years","description":"All treated patients. In this follow-up study, events are displayed cumulatively that occurred in the initial study (1160.20) or in the present study. Most patients changed treatment regimens per amendment during conduct. Events were assigned to the regimen a patient received prior to the event, and patients may be counted in multiple regimens.","eventGroups":[{"id":"EG000","title":"50 mg Once Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate once daily","seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":0,"otherNumAtRisk":1},{"id":"EG001","title":"50 mg Twice Daily","description":"Number of Participants treated at any time with 50 mg of Dabigatran etexilate twice daily","seriousNumAffected":8,"seriousNumAtRisk":105,"otherNumAffected":18,"otherNumAtRisk":105},{"id":"EG002","title":"150 mg Once Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate once daily","seriousNumAffected":20,"seriousNumAtRisk":102,"otherNumAffected":17,"otherNumAtRisk":102},{"id":"EG003","title":"150 mg Twice Daily","description":"Number of Participants treated at any time with 150 mg of Dabigatran etexilate twice daily","seriousNumAffected":153,"seriousNumAtRisk":356,"otherNumAffected":219,"otherNumAtRisk":356},{"id":"EG004","title":"300 mg Once Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate once daily","seriousNumAffected":39,"seriousNumAtRisk":90,"otherNumAffected":65,"otherNumAtRisk":90},{"id":"EG005","title":"300 mg Twice Daily","description":"Number of Participants treated at any time with 300 mg of Dabigatran etexilate twice daily","seriousNumAffected":21,"seriousNumAtRisk":161,"otherNumAffected":57,"otherNumAtRisk":161}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":9,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":5,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":6,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Atrial conduction time prolongation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":12,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Atrial thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":6,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardiac asthma","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":14,"numAtRisk":356},{"groupId":"EG004","numAffected":7,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardiogenic shock","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Conduction disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cor pulmonale","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Mitral valve incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":7,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Sick sinus syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ventricular arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":4,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Retinal haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Abdominal adhesions","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Diverticulum intestinal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Faeces discoloured","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gastric haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":7,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Intestinal ischaemia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Large intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":4,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Oesophageal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pancreatic pseudocyst","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Peritonitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Chest discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":14,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Drug ineffective","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dysplasia","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Sudden cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":2,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hepatic function abnormal","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Drug hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Appendicitis perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Implant site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Infected skin ulcer","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Infective exacerbation of chronic obstructive airways disease","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lobar pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Localised infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Nail infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":15,"numAtRisk":356},{"groupId":"EG004","numAffected":2,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Post procedural infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Chest injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gastrointestinal stoma complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Implantable defibrillator malfunction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Postoperative ileus","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Stent-graft endoleak","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Blood pressure systolic inspiratory decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Electrocardiogram ST segment depression","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Heart rate increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Heart rate irregular","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hepatic enzyme increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Liver function test abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Gouty arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Osteitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Osteoporosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":4,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bladder cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bladder papilloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":2,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bladder transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Bronchial carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Chronic lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Colon cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Metastases to bone","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Metastases to lymph nodes","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Multiple myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Neoplasm skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Non-Hodgkin's lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ovarian cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":6,"numAtRisk":356},{"groupId":"EG004","numAffected":2,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Haemorrhagic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ischaemic cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":3,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":2,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Memory impairment","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Myasthenic syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":7,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Albuminuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Calculus urethral","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal cyst","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal failure acute","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal failure chronic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Renal infarct","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Urethral haemorrhage","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Urinary tract disorder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":5,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cystocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Prostatism","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Rectocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":5,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":9,"numAtRisk":356},{"groupId":"EG004","numAffected":4,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Haemothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Lung infiltration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Restrictive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Skin discolouration","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Joint prosthesis user","organSystem":"Social circumstances","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Cardiac pacemaker replacement","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hip arthroplasty","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Aortic aneurysm rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Aortic dissection","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":2,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Femoral artery aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Femoral artery occlusion","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":4,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Intermittent claudication","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Peripheral embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Peripheral ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Peripheral vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Temporal arteritis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Vasculitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":1,"numAtRisk":356},{"groupId":"EG004","numAffected":0,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Wound haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":0,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":21,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":20,"numAtRisk":356},{"groupId":"EG004","numAffected":8,"numAtRisk":90},{"groupId":"EG005","numAffected":4,"numAtRisk":161}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":19,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":19,"numAtRisk":356},{"groupId":"EG004","numAffected":1,"numAtRisk":90},{"groupId":"EG005","numAffected":4,"numAtRisk":161}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":7,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":14,"numAtRisk":356},{"groupId":"EG004","numAffected":9,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":9,"numAtRisk":105},{"groupId":"EG002","numAffected":4,"numAtRisk":102},{"groupId":"EG003","numAffected":19,"numAtRisk":356},{"groupId":"EG004","numAffected":4,"numAtRisk":90},{"groupId":"EG005","numAffected":6,"numAtRisk":161}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":3,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":22,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":11,"numAtRisk":161}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":3,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":22,"numAtRisk":356},{"groupId":"EG004","numAffected":10,"numAtRisk":90},{"groupId":"EG005","numAffected":6,"numAtRisk":161}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":18,"numAtRisk":356},{"groupId":"EG004","numAffected":5,"numAtRisk":90},{"groupId":"EG005","numAffected":8,"numAtRisk":161}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":4,"numAtRisk":102},{"groupId":"EG003","numAffected":39,"numAtRisk":356},{"groupId":"EG004","numAffected":12,"numAtRisk":90},{"groupId":"EG005","numAffected":10,"numAtRisk":161}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":3,"numAtRisk":105},{"groupId":"EG002","numAffected":6,"numAtRisk":102},{"groupId":"EG003","numAffected":46,"numAtRisk":356},{"groupId":"EG004","numAffected":10,"numAtRisk":90},{"groupId":"EG005","numAffected":8,"numAtRisk":161}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":17,"numAtRisk":356},{"groupId":"EG004","numAffected":5,"numAtRisk":90},{"groupId":"EG005","numAffected":3,"numAtRisk":161}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":22,"numAtRisk":356},{"groupId":"EG004","numAffected":9,"numAtRisk":90},{"groupId":"EG005","numAffected":11,"numAtRisk":161}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":3,"numAtRisk":105},{"groupId":"EG002","numAffected":5,"numAtRisk":102},{"groupId":"EG003","numAffected":43,"numAtRisk":356},{"groupId":"EG004","numAffected":13,"numAtRisk":90},{"groupId":"EG005","numAffected":7,"numAtRisk":161}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":20,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":23,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":19,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":11,"numAtRisk":161}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":17,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":5,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":1,"numAtRisk":161}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":3,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":12,"numAtRisk":356},{"groupId":"EG004","numAffected":5,"numAtRisk":90},{"groupId":"EG005","numAffected":6,"numAtRisk":161}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":3,"numAtRisk":102},{"groupId":"EG003","numAffected":12,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]},{"term":"Hypercholesterolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":6,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":3,"numAtRisk":161}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":3,"numAtRisk":102},{"groupId":"EG003","numAffected":23,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":4,"numAtRisk":161}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":7,"numAtRisk":102},{"groupId":"EG003","numAffected":28,"numAtRisk":356},{"groupId":"EG004","numAffected":13,"numAtRisk":90},{"groupId":"EG005","numAffected":3,"numAtRisk":161}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":11,"numAtRisk":356},{"groupId":"EG004","numAffected":5,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":5,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":4,"numAtRisk":105},{"groupId":"EG002","numAffected":4,"numAtRisk":102},{"groupId":"EG003","numAffected":18,"numAtRisk":356},{"groupId":"EG004","numAffected":7,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":7,"numAtRisk":105},{"groupId":"EG002","numAffected":4,"numAtRisk":102},{"groupId":"EG003","numAffected":36,"numAtRisk":356},{"groupId":"EG004","numAffected":13,"numAtRisk":90},{"groupId":"EG005","numAffected":14,"numAtRisk":161}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":6,"numAtRisk":105},{"groupId":"EG002","numAffected":3,"numAtRisk":102},{"groupId":"EG003","numAffected":22,"numAtRisk":356},{"groupId":"EG004","numAffected":7,"numAtRisk":90},{"groupId":"EG005","numAffected":5,"numAtRisk":161}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":18,"numAtRisk":356},{"groupId":"EG004","numAffected":3,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":2,"numAtRisk":102},{"groupId":"EG003","numAffected":32,"numAtRisk":356},{"groupId":"EG004","numAffected":4,"numAtRisk":90},{"groupId":"EG005","numAffected":4,"numAtRisk":161}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":6,"numAtRisk":356},{"groupId":"EG004","numAffected":6,"numAtRisk":90},{"groupId":"EG005","numAffected":2,"numAtRisk":161}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":5,"numAtRisk":102},{"groupId":"EG003","numAffected":29,"numAtRisk":356},{"groupId":"EG004","numAffected":15,"numAtRisk":90},{"groupId":"EG005","numAffected":9,"numAtRisk":161}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":6,"numAtRisk":102},{"groupId":"EG003","numAffected":37,"numAtRisk":356},{"groupId":"EG004","numAffected":12,"numAtRisk":90},{"groupId":"EG005","numAffected":9,"numAtRisk":161}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":3,"numAtRisk":102},{"groupId":"EG003","numAffected":23,"numAtRisk":356},{"groupId":"EG004","numAffected":10,"numAtRisk":90},{"groupId":"EG005","numAffected":11,"numAtRisk":161}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":12,"numAtRisk":356},{"groupId":"EG004","numAffected":8,"numAtRisk":90},{"groupId":"EG005","numAffected":3,"numAtRisk":161}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":1,"numAtRisk":105},{"groupId":"EG002","numAffected":1,"numAtRisk":102},{"groupId":"EG003","numAffected":17,"numAtRisk":356},{"groupId":"EG004","numAffected":10,"numAtRisk":90},{"groupId":"EG005","numAffected":6,"numAtRisk":161}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":2,"numAtRisk":105},{"groupId":"EG002","numAffected":5,"numAtRisk":102},{"groupId":"EG003","numAffected":32,"numAtRisk":356},{"groupId":"EG004","numAffected":14,"numAtRisk":90},{"groupId":"EG005","numAffected":5,"numAtRisk":161}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1},{"groupId":"EG001","numAffected":0,"numAtRisk":105},{"groupId":"EG002","numAffected":0,"numAtRisk":102},{"groupId":"EG003","numAffected":3,"numAtRisk":356},{"groupId":"EG004","numAffected":5,"numAtRisk":90},{"groupId":"EG005","numAffected":0,"numAtRisk":161}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract"},"pointOfContact":{"title":"Boehringer Ingelheim Call Center","organization":"Boehringer Ingelheim Pharmaceuticals","email":"clintriage.rdg@boehringer-ingelheim.com","phone":"1-800-243-0127"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000069604","term":"Dabigatran"}],"ancestors":[{"id":"D000000991","term":"Antithrombins"},{"id":"D000015842","term":"Serine Proteinase Inhibitors"},{"id":"D000011480","term":"Protease Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000000925","term":"Anticoagulants"}],"browseLeaves":[{"id":"M490","name":"Dabigatran","asFound":"4 hours","relevance":"HIGH"},{"id":"M3997","name":"Antithrombins","relevance":"LOW"},{"id":"M3996","name":"Antithrombin III","relevance":"LOW"},{"id":"M14033","name":"Protease Inhibitors","relevance":"LOW"},{"id":"M18081","name":"Serine Proteinase Inhibitors","relevance":"LOW"},{"id":"M19299","name":"HIV Protease Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M3934","name":"Anticoagulants","relevance":"LOW"},{"id":"T18","name":"Serine","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"AA","name":"Amino Acids"}]}},"hasResults":true}